当前位置: 首页 >> 检索结果
共有 9618 条符合本次的查询结果, 用时 8.3955546 秒

261. Association of red blood cell distribution width with short- and long-term all-cause mortality in patients with acute pancreatitis and sepsis.

作者: Qingzhou Song.;Xuanlin Wu.;Firooz Ahmad Taheri.;Linghou Meng.;Wentao Wang.;Xianwei Mo.
来源: BMC Gastroenterol. 2025年25卷1期539页
The association between red blood cell distribution width (RDW) and short- and long-term all-cause mortality in patients with acute pancreatitis (AP) and sepsis remains unclear.

262. Unraveling the link between inflammatory bowel disease and perianal abscess: insights from bidirectional and multivariable Mendelian randomization study.

作者: Haoqi Zhu.;Jingyi Pan.
来源: BMC Gastroenterol. 2025年25卷1期538页
Emerging epidemiological studies have identified associations between perianal abscess (PA) and inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), though the pathophysiological mechanisms underlying their comorbidity remain incompletely understood. To elucidate potential causal relationships between these clinical entities, we conducted a comprehensive investigation employing bidirectional two-sample Mendelian randomization (MR) analysis complemented by multivariable Mendelian randomization (MVMR) methodology. This analytical approach enables systematic evaluation of causal directionality while accounting for potential confounding factors inherent in observational studies.

263. Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease.

作者: Yang Yang.;Cheng Zeng.;Zhiqiang Jin.;Yi Huang.;Huabao Liu.
来源: BMC Gastroenterol. 2025年25卷1期537页
Cardiometabolic Index (CMI) is positively correlated with liver fibrosis in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), but its association with mortality risk in MASLD patients remains unclear.

264. Correlation between systemic inflammatory response syndrome and prognosis of patients with cirrhosis and hepatic encephalopathy.

作者: Kaiyue Zhang.;Ziqun Qu.;Rongyu Tang.;Hongliang Dong.;Jing Fan.;Wei Ye.
来源: BMC Gastroenterol. 2025年25卷1期536页
Although systemic inflammatory response syndrome (SIRS) is associated with the progression of cirrhosis, its clinical significance in patients with cirrhosis and hepatic encephalopathy (HE) remains unclear.

265. Management and outcomes of patients with obstructive jaundice from pancreatobiliary diseases in Rwanda.

作者: Zainab Ingabire.;Aberra B Hanna.;Emile Sebera.;Janvier Murayire.;Gamal S Mohamed.;Eric Rutaganda.;Felicien Shikama.;Marie Solange Mukanumviye.;Dyna Nyampinga.;Innocenti Dadamessi.;Kulwinder Dua.;Redae Berhane.
来源: BMC Gastroenterol. 2025年25卷1期535页
Obstructive jaundice from pancreatobiliary diseases represents a significant global health challenge, particularly in resource-limited settings like Rwanda. While endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD) are now available at tertiary centers in Kigali, there is limited local clinical data on the management and outcomes of these conditions. This study aims to assess the patterns, therapeutic approaches, and outcomes of obstructive jaundice in the Rwandan healthcare context.

266. Analysis of influencing factors and nursing strategies for enteral nutrition patients complicated with refeeding syndrome in ICU.

作者: Dongmei Yan.;Jian Wang.
来源: BMC Gastroenterol. 2025年25卷1期534页
To analyze the influencing factors and nursing strategies for enteral nutrition patients complicated with refeeding syndrome (RS) in the ICU.

267. LINC00634 is a novel prognostic biomarker for colon cancer associated with immune infiltration.

作者: Haiyan Wang.;Yanyan Huang.;Lina Zhou.;Xiaotong Zhu.;Xuan Ye.;Yi Cen.
来源: BMC Gastroenterol. 2025年25卷1期533页
Colon cancer is a highly heterogeneous and most common malignant tumor of the gastrointestinal tract, which is prone to metastasis in advanced stages, leading to a poor prognosis for patients.

268. Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China.

作者: Hao Zhang.;Xue-Li Ding.;Yong-Hong Xu.;Jun Wu.;Yue-Yuan Wang.;Shu-Xian Liu.;Jing Yan.;Hua Liu.;Zi-Bin Tian.;Ai-Ling Liu.
来源: BMC Gastroenterol. 2025年25卷1期531页
Limited data exist regarding the efficacy and safety of vedolizumab (VDZ) in China's elderly adult population with ulcerative colitis (UC) in China. In this investigation, a comparative analysis of its efficacy and safety was performed between elderly and younger adult UC cohorts.

269. Development and validation of a nomogram-based risk prediction model for non-alcoholic fatty liver disease (NAFLD): a logistic regression analysis in a physical examination population.

作者: Jing Lan.;Ting Que.;Hong Lan.;Mingming Zhang.;Lichan Ban.
来源: BMC Gastroenterol. 2025年25卷1期532页
The global prevalence of non-alcoholic fatty liver disease (NAFLD) has reached an alarming 25%, based on recent population-based studies. NAFLD diagnosis primarily relies on imaging methods, which may be invasive, costly, or limited. Existing prediction models, such as the Fatty Liver Index (FLI) and NAFLD Liver Fat Score (NLFS), mainly incorporate metabolic parameters from Western populations and neglect non-metabolic factors, limiting their generalizability. To address these limitations, this study developed a screening model integrating both metabolic and non-metabolic indicators, tailored specifically to diverse populations undergoing routine physical examinations.

270. Correction: Accuracy of the diagnosis of gastroesophageal reflux disease by a trial of potassium-competitive acid blocker treatment.

作者: Peiwen Dong.;Lin Lin.;Kaidi Sun.;Feng Tang.;Qian Li.;Xinxu Zhou.;Fuli Liu.;Zhilin Yang.;Jiao Li.;Lin Jiang.;Ping Zhao.;Xiaobin Sun.;Qiong Wang.
来源: BMC Gastroenterol. 2025年25卷1期530页

271. Probiotics for postcolonoscopy gastrointestinal discomfort from current evidence to future perspectives.

作者: Federica DI Vincenzo.;Elena Cardinali.;Pierluigi Puca.;Loris R Lopetuso.
来源: Minerva Gastroenterol (Torino). 2025年71卷2期83-85页

272. Sex-specific adverse effects of lipid accumulation products and cardiometabolic indices on the prevalence of gallstones: insights from the 2017-2020 national health and nutrition examination survey.

作者: Yangyang Zheng.;Xiaoli Chen.;Yunpeng Ge.;Haowei Shi.;Shiqi Guo.;Wendan Tan.;Jinghai Song.
来源: BMC Gastroenterol. 2025年25卷1期529页
Anthropometric measurements and lipid profiles are associated with the onset of gallstone disease, with these associations exhibiting sex-specific variations. This study investigated the association between the prevalence of gallstones and two anthropometric-lipid markers, namely Lipid Accumulation Products (LAP) and Cardiometabolic Index (CMI), while also assessing the presence of sex disparities.

273. Global burden of esophageal diseases: a comprehensive analysis of disease trends and risk factors from 1990 to 2021.

作者: Yanbin Wei.;Endian Liu.;Jiafei Peng.;Yanqing Liu.;Xiujing Sun.;Xin Yao.
来源: BMC Gastroenterol. 2025年25卷1期528页
Esophageal diseases (ED) are a common category of upper gastrointestinal disorders, mainly including gastroesophageal reflux disease (GERD), esophagitis, Barrett's esophagus, achalasia, and esophageal cancer (EC). In recent years, the high recurrence rate of GERD and poor prognosis of EC are paid more attention, collectively contributing to the global burden of ED.

274. Development and validation of predictive models for disease-free survival and overall survival in non-metastatic right-sided colon adenocarcinoma patients based on inflammatory and nutritional indices.

作者: Yifan Zhang.;Yun Zhou.;Chengjun Wu.;Cheng Ma.
来源: BMC Gastroenterol. 2025年25卷1期527页
This study developed and validated prognostic nomograms incorporating inflammatory and nutritional biomarkers to predict disease-free survival (DFS) and overall survival (OS) in patients with non-metastatic right-sided colon adenocarcinoma (NRCA).

275. The effect of neoadjuvant chemoradiation therapy in resectable pancreatic cancer was independent of intratumoral vascularization.

作者: Tomomi Yasue.;Reiko Ashida.;Ryoji Takada.;Kenji Ikezawa.;Kazuyoshi Ohkawa.;Shigenori Nagata.;Teruki Teshima.;Hirofumi Akita.;Hidenori Takahashi.;Yuichiro Doki.;Hidetoshi Eguchi.
来源: BMC Gastroenterol. 2025年25卷1期526页
Contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) has promising potential in the diagnosis of pancreatic tumors, assessment of fibrosis, and prediction of chemotherapy efficacy. We hypothesize that radiation therapy might reduce variations in chemotherapeutic efficacy caused by fibrosis-induced blood flow disparities, as we explored the relationship between CH-EUS patterns and the efficacy of neoadjuvant chemoradiotherapy (NACRT) in resectable pancreatic cancer (PC).

276. Risk-Adapted Starting Ages for Colorectal Cancer Screening Based on Comprehensive Family History.

作者: Teresa Seum.;Michael Hoffmeister.;Hermann Brenner.
来源: Gastroenterology. 2025年169卷6期1298-1300页

277. The effectiveness of combining ursodeoxycholic acid with vitamin D in treating patients with primary biliary cholangitis and its impact on hepatic fibrosis: a randomized trial.

作者: Yilihamu Abulitifu.;Mierzhati Maimaiti.;Fengcong Zhao.;Munire Adilijiang.;Wen Qian.;Yongping Zhang.
来源: BMC Gastroenterol. 2025年25卷1期525页
To investigate the effectiveness of combining ursodeoxycholic acid (UDCA) and vitamin D (VitD) in treating patients with primary biliary cholangitis (PBC) and its impact on hepatic fibrosis.

278. Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease.

作者: Hanaa Badran.;Maha Elsabaawy.;Mai Magdy.;Hazem Omar.;Olfat Hendy.;Eman Awaad.;Maymona Abd El-Wahed Al-Khalifa.;Mai Abozeid.
来源: BMC Gastroenterol. 2025年25卷1期524页
Circulating platelet-derived growth factor receptor-β (PDGFRβ) has recently been found to correlate with severity of liver disease in multiple etiologies, including liver steatosis. In diabetic patients with metabolic-associated fatty liver disease (MAFLD), widely used non-invasive scoring systems, particularly the fibrosis-4 (FIB-4) score, showed unsatisfactory performance in predicting liver fibrosis severity. The aim of this study was to evaluate the productivity of serum PDGFRβ as a non-invasive biomarker of liver fibrosis in diabetic MAFLD patients.

279. Interferon therapy for chronic hepatitis B virus infection affects nucleoside metabolism: a metabolomics study.

作者: Xiangyang Ye.;Rongxian Qiu.;Xiongzhi He.;Zhenting Hu.;Fengfeng Zheng.;Xiaogang Huang.;Xuemei Xie.;Feihua Chen.;Hanbing Ou.
来源: BMC Gastroenterol. 2025年25卷1期523页
Pegylated interferon alfa (pegIFN-α) is one of the main therapeutic strategies for chronic hepatitis B (CHB) infection. Although interferon-based treatment strategies have great potential in combating CHB, they have significant side effects, and many patients do not respond. In this study, nontargeted metabolomics was performed to investigate the effects of interferon therapy on metabolites and their correlations with clinical indicators. Each group of 20 patients received PEG-IFN alfa-2b for 0, 1, 3, or 6 months. At the end of the IFN-α treatment, patient serum samples were processed for clinical, biological, and metabolomic analyses. The results revealed that in all four groups, the most affected metabolic pathways were ABC transporter, caffeine metabolism, and protein digestion and absorption. Notably, among the top 8 differentially abundant metabolites with high ROC AUC values (≥ 0.95), three were related to pyrimidine nucleoside metabolites (cytidine, 3-methyluridine and ribothymidine), indicating the pivotal role of altered nucleoside metabolism in HBV infection and suggesting that IFN-α treatment might partially correct this dysregulation. The top 20 metabolites were strongly associated with clinical indicators, with significant differences after IFN-α treatment, and may serve as promising biomarkers for monitoring HBV progression and the therapeutic effect of IFN-α treatment for chronic HBV infection.

280. Early acetaminophen administration and mortality outcomes in critically ill patients with cirrhosis: a retrospective analysis from the MIMIC-IV database.

作者: Xiao-Fei Fan.;Shao-Kang Xu.;Shen-Ao Fu.;Xuan He.;Jia-Kai Fang.;Wen Gao.;Na Guo.
来源: BMC Gastroenterol. 2025年25卷1期522页
Cirrhosis is a major global health burden, often requiring ICU admission due to complications. Acetaminophen (APAP) is frequently used for pain and fever management in critically ill patients, but its safety in cirrhotic patients remains uncertain.
共有 9618 条符合本次的查询结果, 用时 8.3955546 秒